These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 31095692

  • 21. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA.
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [Abstract] [Full Text] [Related]

  • 22. Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users.
    Huestis MA, Blount BC, Milan DF, Newmeyer MN, Schroeder J, Smith ML.
    Drug Test Anal; 2019 Jul; 11(7):968-975. PubMed ID: 30756523
    [Abstract] [Full Text] [Related]

  • 23. Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections.
    Smith ML, Barnes AJ, Huestis MA.
    J Anal Toxicol; 2009 May; 33(4):185-9. PubMed ID: 19470219
    [Abstract] [Full Text] [Related]

  • 24. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C, Scheidweiler KB, Barnes AJ, Huestis MA.
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans.
    Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA.
    Clin Chem; 2003 Jul; 49(7):1114-24. PubMed ID: 12816908
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.
    Milman G, Barnes AJ, Schwope DM, Schwilke EW, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA.
    Anal Bioanal Chem; 2011 Aug; 401(2):599-607. PubMed ID: 21637933
    [Abstract] [Full Text] [Related]

  • 29. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA, Lee D, Concheiro-Guisan M, Scheidweiler KB, Gorelick DA, Huestis MA.
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [Abstract] [Full Text] [Related]

  • 30. Automated extraction and LC-MS-MS analysis of 11-nor-9-carboxy-tetrahydrocannabinol isomers and prevalence in authentic urine specimens.
    Karas LK, Patterson C, Fuller ZJ, Karschner EL.
    J Anal Toxicol; 2024 May 20; 48(4):197-203. PubMed ID: 38581658
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence.
    Goodwin RS, Darwin WD, Chiang CN, Shih M, Li SH, Huestis MA.
    J Anal Toxicol; 2008 Oct 20; 32(8):562-9. PubMed ID: 19007504
    [Abstract] [Full Text] [Related]

  • 35. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
    Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Herning RI, Cadet JL, Huestis MA.
    J Anal Toxicol; 2009 Oct 20; 33(8):469-77. PubMed ID: 19874654
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products.
    Bergeria CL, Spindle TR, Cone EJ, Sholler D, Goffi E, Mitchell JM, Winecker RE, Bigelow GE, Flegel R, Vandrey R.
    J Anal Toxicol; 2022 Jul 14; 46(6):583-591. PubMed ID: 35438179
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users.
    Lewis J, Molnar A, Allsop D, Copeland J, Fu S.
    Int J Legal Med; 2016 Jan 14; 130(1):147-52. PubMed ID: 26233612
    [Abstract] [Full Text] [Related]

  • 40. Passive cannabis smoke exposure and oral fluid testing.
    Niedbala S, Kardos K, Salamone S, Fritch D, Bronsgeest M, Cone EJ.
    J Anal Toxicol; 2004 Oct 14; 28(7):546-52. PubMed ID: 15516313
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.